Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer
作 者
详细资料
相关链接
DOI URL
阿平 的文献笔记 订阅 |
复发性卵巢癌
免疫治疗+抗血管 治疗在铂类药物敏感的病人中有效率高达40%,而在铂类化疗不敏感者只有16%,看来有潜力可挖。 |

A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling
Oncogenic Signaling Alters Cell Shape and Mechanics to Facilitate Cell Division under Confinement